76.06USD-2.21%Mkt Cap: 10.65B USDP/E: —Last update: 2026-06-01
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasir…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap10.65B USD
Enterprise Value10.56B USD
Revenue (TTM)622.01M USD
Gross Profit622.01M USD
Net Income (TTM)-1.63M USD
Revenue/Share4.471 USD
Last Price76.06 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees711
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS04280A1007
Valuation
P/E (Trailing)—
P/E (Forward)-17.95
PEG—
EV/EBITDA-53.74
EV/Revenue16.98
P/S17.64
P/B17.84
EPS (TTM)-2.27
EPS (Forward)-4.34
52W Range
14.3091% of range82.26
52W High82.26 USD
52W Low14.30 USD
Profitability
Gross Margin100.00%
Oper. Margin-191.57%
EBITDA Margin-31.60%
Profit Margin-0.20%
ROE-0.35%
ROA-0.12%
Growth
Revenue Growth-86.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF179.55M USD
CapEx (TTM)22.67M USD
FCF Margin-7.41%
FCF Yield-0.43%
Net Debt-398.40M USD
Net Debt/EBITDA2.03
Balance Sheet
Debt/Equity0.79
Current Ratio6.23
Quick Ratio6.09
Book Value/Sh4.368 USD
Cash/Share12.65 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateNov 17, 2011
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)88.17 USD
Target Range46.00 USD – 110.00 USD
# Analysts12
Ownership
Shares Out.140.86M
Float122.78M
Insiders3.76%
Institutions88.56%
Short Interest
Short Ratio6.8d
Short % Float12.78%
Short % Out.9.18%
Shares Short12.93M
Short (prev mo.)12.01M
Technical
SMA 5069.44 (+9.5%)
SMA 20054.04 (+40.7%)
Beta1.29
S&P 52W Chg27.94%
Avg Vol (30d)1.57M
Avg Vol (10d)1.57M
Technical Indicators
RSI (14)55.8
MACD2.0158
MACD Signal2.2236
MACD Hist.-0.2078
BB Upper81.11 USD
BB Middle76.80 USD
BB Lower72.48 USD
BB Width11.24%
ATR (14)3.627 USD
Vol Ratio (20d)0.42x